Condition: Neuroendocrine Tumors · Gep Net · Pulmonary Neuroendocrine Neoplasm · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational ambispective monocentric study on the clinical, laboratory, pathological and molecular characteristics of patients suffering from gastroenteropancreatic tract and pulmonary neuroendocrine tumors and their prognostic and predictive value.
This description comes directly from the study's public registry record.
Maria Grazia Maratta, MD · +39 0630156318 · mariagrazia.maratta@guest.policlinicogemelli.it
Giovanni Schinzari, MD · +39 0630156318 · giovanni.schinzari@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario Agostino Gemelli - IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06402695